Andres
Iñiguez Romo
![Foto de Andres](/img/nophoto.png)
![Foto de Instituto Dante Pazzanese de Cardiologia](/img/noimage_org.png)
Instituto Dante Pazzanese de Cardiologia
São Paulo, BrasilPublicacións en colaboración con investigadores/as de Instituto Dante Pazzanese de Cardiologia (5)
2020
-
Impact of vascular access on outcome after PCI in patients at high bleeding risk: a pre-specified sub-analysis of the LEADERS FREE trial
Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 536-545
2017
-
ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy
Basic and Clinical Pharmacology and Toxicology, Vol. 120, Núm. 5, pp. 466-474
2015
-
Polymer-free drug-coated coronary stents in patients at high bleeding risk
New England Journal of Medicine, Vol. 373, Núm. 21, pp. 2038-2047
2013
-
Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients
Clinica Chimica Acta, Vol. 425, pp. 9-17
2012
-
Increased clopidogrel response is associated with ABCC3 expression: A pilot study
Clinica Chimica Acta, Vol. 413, Núm. 3-4, pp. 417-421